Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is entitled “분기보고서” (Quarterly Report) covering the period 2026-01-01 to 2026-03-31 for Hitec Pharm. It includes detailed financial statements, management discussion of results, business overview, capital changes, and operational data. This matches the definition of an Interim / Quarterly Report (IR), containing substantive financial data for a period shorter than a full fiscal year. Q1 2026
2026-05-15 Korean
대표이사변경
Board/Management Information Classification · 95% confidence The document is a notice of change in the company’s representative director (CEO) including details of outgoing and incoming executives, board resolution date, and background. This aligns with an announcement of changes in senior management. Therefore, it is classified as Board/Management Information (MANG).
2026-04-27 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 80% confidence The document is a company announcement detailing the exercise of stock options (주식매수선택권 행사), including the number of shares to be issued or settled, exercise dates, and method of settlement. This relates to a change in the company’s capital structure via option exercises. It is not a full financial report, management presentation, or regulatory notice alone, but specifically concerns share issuance/capital change. Therefore, it falls under the "Share Issue/Capital Change" category (SHA).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 98% confidence The document is a statutory “주식등의 대량보유상황보고서(일반)” filed under the Korean Capital Markets Act, reporting a change in large shareholdings (crossing reporting thresholds) by ACS DOBFAR S.P.A and related parties. It details share counts, ownership percentages, beneficial owners, and reasons for changes. This corresponds exactly to the Major Shareholding Notification category (MRQ).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 98% confidence The document is a formal ‘주식등의 대량보유상황보고서(일반)’ which provides detailed information on the number of shares held, percentage holdings, changes in significant share ownership, reasons for changes, and related parties. This aligns with a Major Shareholding Notification (reporting material shareholdings and thresholds under the Capital Markets Act), matching our category “Major Shareholding Notification (Code: MRQ).” It is not an earnings release, board management announcement, or share issuance; it is a direct notification of substantial shareholding changes.
2026-03-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a mandatory disclosure of share ownership by a company officer/major shareholder, detailing the number of shares held, changes in holdings, and related information under securities regulations. This matches the insider transaction / director dealing category rather than a broad financial report or announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2026-03-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.